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Hölsö K, Rantala M, Lillas A, Eerikäinen S, Huovinen P, Kaartinen L: Prescribing
antimicrobial agents for dogs and cats via university pharmacies in Finland –  pat-
terns and quality of information. Acta vet. scand. 2005, 46, 87-93. – The aim of our
study was to evaluate antimicrobial use in dogs and cats in Finland. Information on vet-
erinary prescriptions was gathered from University Pharmacies (n=17) over a one-
month period, April 2001. A total of 2719 prescriptions for veterinary use were deliv-
ered, of which the majority were for dogs (70%, n=1898) and cats (14%, n=384). The
most prescribed therapy group was per-oral antimicrobial agents (53%, n=1449), of
which 16% (n=237) were medicines approved for humans. The most commonly used
substances for dogs and cats were betalactams, 66% and 78%, respectively. The pro-
portion of fluoroquinolones was 3-5%. The average duration of the treatment periods
was 10 days with the exception of treatment of cats with macrolide-lincosamides, where
the mean period was 20 days. Indication was mentioned only in 37% of the prescrip-
tions. 
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Introduction
Reports on antimicrobial consumption and oc-
currence of antimicrobial resistance in veteri-
nary medicine are provided from some coun-
tries (FINRES-Vet 2002-2003, MARAN 2002,
SVARM 2002, DANMAP 2003, NORM/NORM-
VET 2003). Consumption figures on antimicro-
bial agents in Finland are based on wholesalers'
statistics and give a good overall estimate of to-
tal drug use in animals. However, this informa-
tion gives only a rough estimate on how drugs
are used in different animal species since sev-
eral drugs are authorised for a number of
species. In addition, these data do not provide
any information on the amount of human
medicinal products used for veterinary pur-
poses. Earlier studies have shown that the ma-
jority of human medicines prescribed for vet-
erinary purposes, especially antimicrobials, are
used for companion animals (Bingefors 1985,
Grave et al. 1992). The information on the
amount of human medicines used for compan-
ion animals is important for making more accu-
rate estimations of total antimicrobial con-
sumption in these species. Studies of indi-
cation-based use of antimicrobials in animals
are scarce (Watson 1990, Watson & Maddison
2001). 
In accordance with the European Union rules
(directive 2001/82/EEC) the first treatment op-
tion should be a veterinary product approved
for the particular animal species to be treated.
If no such product is available, a veterinary
product approved for another animal species
should be used. The use of human medicinal
products is allowed only if a suitable veterinary
product for another animal species does not ex-
ist. Because consumer safety is not an issue in
the treatment of companion animals – as it is in
food-producing animals – veterinarians can use
medicines for companion animals more liber-
ally. 
This survey was carried out to assess what kind
of antimicrobial agents are prescribed via Uni-
versity Pharmacies for treating infections in
companion animals in Finland, and how large a
proportion of the veterinary antimicrobial pre-
scriptions were human medicinal products. We
also investigated the quality of information
given on prescriptions, and gathered informa-
tion from indications. 
Materials and methods
In a cross-sectional retrospective prescription
study, the University Pharmacies were asked to
gather data of every veterinary prescription de-
livered during a one-month period, April 2001.
At the time there were 17 University Pharma-
cies located in cities in different parts of the
country: Helsinki (five), Joensuu, Jyväskylä
(two), Kemi, Lahti, Lappeenranta, Oulu, Pori,
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Figure 1: Upper panel: prescribed per-oral antimicrobials for dogs (n=678) and cats (n=196). Lower panel: Dis-
tribution of per-oral betalactam antimicrobials for dogs (n=448) and cats (n=153). 
Salo, Savonlinna, Tampere and Turku. We
chose to use University Pharmacies as sources
for data collection, because their location is
representative of the most populated areas in
Finland. The following information was col-
lected from prescription records: animal
species, trade name of the product, strength of
the formula, package size, duration of the treat-
ment period and indication. The pharmacies
were also asked to provide the number of all
prescriptions dispensed during the follow-up
period. Human and veterinary drugs and active
substances were coded. Data was sorted by an-
imal species and whether the drug was ap-
proved only for human use. Antimicrobial
agents were further divided into subgroups ac-
cording to their active substances, and mean
treatment periods for different groups were cal-
culated. 
Results
All 17 University Pharmacies provided the re-
quested information. A total of 2719 drug pre-
scriptions for veterinary use were dispensed
during April 2001 via University Pharmacies.
The proportion of veterinary prescriptions var-
ied from 0.01% to 17% between pharmacies
and the mean was 1%. The majority of veteri-
nary prescriptions were written for dogs (70%,
n=1898) and cats (14%, n=384). The rest was
for horses (3%, n=80) and for other species
(5%; cows, rodents, fish, pigs, birds etc.).
Species was not mentioned in 8% of the pre-
scriptions.
Antimicrobial agents were the most commonly
prescribed medicines for animals and repre-
sented 53% of all veterinary prescriptions. Oral
antimicrobial agents were prescribed in 1038
prescriptions, of these 678 (65%) were for dogs
and 196 (19%) for cats. Thirty-six percent of all
canine prescriptions contained an oral antimi-
crobial agent, and the respective percentage for
cats was 51%. The distribution of different an-
timicrobial groups prescribed for dogs and cats
is presented in Figure 1. Of canine oral antimi-
crobial prescriptions, 66% (n=448) were beta-
lactams. Amoxicillin-clavulanate and cepha-
lexin were the most used betalactams and
represented 83% of all betalactams for dogs
(Figure 1). Betalactams made 78% (n=153) of
feline oral antimicrobial prescriptions (Figure
1). The distribution of betalactams in cats was
the following: amoxicillin 52%, (n=80), amox-
icillin-clavulanate 38% (n=58) and cephalexin
10% (n=15) (Figure 1).  
A human medicinal product had been pre-
scribed for veterinary use in 851 cases (31% of
all drugs for veterinary use). Of these 179 were
oral antimicrobial agents and 59 topical antimi-
crobial products. Human medicinal products
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Table 1. Number (%) of human medicines prescribed for animals within different antimicrobial groups.
Antimicrobial group Human approved Veterinary approved
product product Total
Betalactams 73 (11%) 586 (89%) 659
Trimethoprim-sulfonamides 35 (18%) 163 (82%) 198
Macrolide-lincosamides 17 (22%) 61 (78%) 78
Fluoroquinolones 10 (26%) 28 (74%) 38
Tetracyclines 9 (35%) 17 (65%) 26
Aminoglycosides - 4 (100%) 4
Nitroimidazoles, nitrofurans 
and antifungals 35 (100%) - 35
represented 17% (n=179) of all oral antimicro-
bial agents for veterinary use. No difference
was detected in the proportion of prescribed hu-
man oral antimicrobial agents for dogs (15%)
compared with cats (16%). Nitroimidazoles, ni-
trofurans and antifungals prescribed were all
human medicinal products, but of betalactams
the respective proportion was only 11% (Table
1). Topical antimicrobial agents had been writ-
ten in 411 prescriptions; 67% were for dogs, 7%
for cats and the rest for other species. The indi-
cation for the majority of topical antimicrobials
was treatment of canine or feline skin, ear or
eye infections. Most frequently preparations
contained polymyxin B (n=106), fusidic axid
(n=96), or chloramphenicol (n=79). Mupirocin
was prescribed in three cases for dogs. 
The duration of the treatment period was not
mentioned in 239 (23%) of oral antimicrobial
prescriptions. The mean duration of the treat-
ment period of the most frequently used oral
antimicrobial agents varied from 9 to11 days in
dogs and from 9 to 20 days in cats (Table 2). In
cats, long treatment periods especially with
azithromycin and erythromycin were used, but
indication was not mentioned in any of these
prescriptions. Neither of these two macrolides
was prescribed for dogs. 
There was no information on the indication in
65% of cats' and in 73% of dogs' antimicrobial
prescriptions. In the prescriptions in which in-
dication was mentioned, the majority of the be-
talactams in dogs was used for treatment of skin
or wound infections. However, a relatively large
proportion of dogs' betalactam prescriptions,
17%, were written for unspecified infections.
Most of the trimethoprim-sulphonamides for
dogs were used for urinary and gastrointestinal
infections. In cats, most of the betalactams were
for the treatment of urinary infections and so
were the fluoroquinolones. Unspecified infec-
tion was mentioned as an indication in 11% of
betalactam prescriptions for cats. 
Discussion
In our study, oral antimicrobials were the most
commonly prescribed medicines (38%) for
companion animals. If topically administered
antimicrobials are taken into account, the pro-
portion of antimicrobials was even higher. Our
result was in agreement with Grave et al.
(1992), who reported that systemic antimicro-
bials were the most commonly prescribed
medicines for animals in Norway. We detected
no significant difference in the use of human
medicinal antimicrobial agents between dogs
and cats: 15-16% of per-oral antimicrobial pre-
scriptions for both of these species were human
medicinal products. In the Norwegian study
80% and 50% of antimicrobials for cats and
dogs, respectively, were human medicines
(Grave et al. 1992). In Sweden, 20% and 13%
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Table 2. The mean duration of the treatment periods in days (range) with different antimicrobials. Only pre-
scriptions in which length of the treatment period has been mentioned were included.
Antimicrobial (n=dogs/cats) Dog Cat
Penicillin V or amoxicillin (73/80) 8.6 (5-15) 9.4 (5-14)
Amoxicillin-clavulanate (172/58) 9.5 (5-21) 8.6 (3-10)
Cephalexin (203/15) 11.4 (3-40) 9.2 (7-14)
Trimethoprim-sulfonamides (119/7) 8.7 (6-10) 11.3 (7-30)
Macrolide-lincosamides (53/17) 11.0 (3-25) 20.0 (7-48)
Fluoroquinolones (22/9) 10.6 (7-14) 12.0 (8-21)
of antimicrobial prescriptions for dogs and cats
were human medicines during the period 1990-
1998 (Odensvik et al. 2001). These differences
may reflect differences in availability of autho-
rised veterinary medical products. 
According to our results, the most used antimi-
crobial group in dogs and cats was betalactams.
Betalactam use in dogs was predominantly
cephalexin and amoxicillin-clavulanate. In cats
approximately one half of the used betalactams
was amoxicillin and the other half was amoxi-
cillin-clavulanate. Betalactams were also the
most popular antimicrobial group used for cats
and dogs in Sweden (Odensvik et al. 2001). In
Australia cephalexin and amoxicillin-clavu-
lanate were the most used antimicrobials both
in feline and canine practice (Watson 1990,
Watson & Maddison 2001). This is in contrast
to Norway, where during the period 1990-1998,
75% of the prescribed veterinary antimicrobials
for cats and dogs were trimethoprim-sul-
phonamides (Odensvik et al. 2001). In dogs,
trimethoprim-sulphonamides followed betalac-
tams in our study (Figure 1). In cats, the second
most used antimicrobial class after betalactams
was macrolide-lincosamides. Only a few per-
cent of prescriptions for both species were
fluoroquinolones, but according to the sale
statistics of National Agency of Medicine
(www.nam.fi) there seems to be a trend of in-
creased use of fluoroquinolones for companion
animals in Finland. The proportion of human
medicines varied within different antimicrobial
groups, being lowest in the betalactam group,
which indicates a good availability of betalac-
tams as veterinary products in Finland. 
Some authors have suggested that veterinarians
may adopt drugs with wider spectrum in small
animal practice without clear justification
(Bingefors 1985, Warren et al. 2001). Espe-
cially the use of new-generation antimicrobials
should be carefully considered (Barton 2001).
In our study, the use of mupirocin may be an ex-
ample of unnecessary antimicrobial use in vet-
erinary medicine. Mupirocin is used for eradi-
cation of methicillin resistant Staphylococcus
aureus (MRSA) from carriers in human
medicine. It can also be used for treating skin
infections in companion animals (Werckenthin
et al. 2001), but resistance situation among ca-
nine staphylococci does not justify the use of
this product in veterinary medicine in Finland
(Rantala et al. 2004). The other concern is the
use of macrolides for long periods. Especially
the use of long-acting macrolides has been as-
sociated to development of resistance (Baquero
1999). Azithromycin has been suggested as an
option in treating chlamydia infections in cats
(Owen et al. 2003). In this study, azithromycin
and erythromycin were the second most used
drugs in cats after betalactams. The mean treat-
ment period was 20 days, but no indications
were mentioned. Azithromycin has not been
proven to have better efficacy than doxycycline
in treating chlamydia infection in cats (Owen et
al. 2003) and we did not found controlled stud-
ies about its use in other feline infections. The
third concern is the relatively liberal use of
wider-spectrum betalactams, amoxicillin-cla-
vulanate and first generation cephalosporins, in
companion animals especially for unspecified
infections.
Legal regulations require that indication should
be given in prescriptions along with other in-
formation. In our study, the lack of this infor-
mation in more than 60% of prescriptions made
it impossible to get reliable results of the indi-
cation-based use of antimicrobials. Grave et al.
(1991) reported that only one fifth of veterinary
prescriptions gave full information, which is
demanded by legislation also in Norway. The
absence of important written information may
lead to incompliance of the implementation of
the prescribed treatment by animal owners. It
has been shown in studies made in human
medicine that it is important for drug compli-
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ance how information is given in prescriptions,
especially in short term therapy (Morris &
Halperin 1979). 
In conclusion, antimicrobials are the most com-
monly prescribed medicines in companion ani-
mal practice and also human medicines are fre-
quently used for treating infections in dogs and
cats. A more suitable drug formula, strength,
package size or non-availability of a compara-
ble veterinary product may be reasons why hu-
man medicines are so widely used in compan-
ion animal practise. The results of this study
indicate that part of the antimicrobial use may
be inadequately justified, and there is a need for
further surveys about indication-based use of
antimicrobials in veterinary medicine. Without
this information it is impossible to estimate
how the recent national recommendations of
antimicrobial use (MMM 2003) are followed.
Lack of important information on prescriptions
may also lead to drug incompliance and inade-
quate treatment of infectious diseases, which
can, in turn, lead to development of antimicro-
bial resistance. Deficiencies in drug prescrip-
tions is also an important issue to take into con-
sideration when teaching veterinary students. 
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Sammanfattning
Målet med vår studie var att utvärdera användningen
av antimikrobiella substanser hos hundar och katter i
Finland. Uppgifterna samlades från djurrecept expe-
dierade från 17 Universitets Apotek under en månads
tid, april år 2001. Sammanlagt 2719 djurrecept expe-
dierades, varav största delen var ämnade för hundar
(70%, n=1898) och katter (14%, n=384). Antibiotika
för oralt bruk var den mest förskrivna läkemedels-
gruppen (53%, n=1449). Av dessa var 16% produk-
ter godkända för humant bruk. De mest använda an-
timikrobiella substanser för hundar och katter var
betalaktamer, 66% respektive 78%. Andelen fluo-
rokinoloner var 3-5%. Kurernas längd var i medeltal
tio dagar, med undantag av makrolider-linkosamider
förskrivna för katter, för dessa var kurens längd i
medeltal 20 dagar. Det fanns indikation nämnt på en-
dast 37% av recepten. 
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